About SynPhNe
SynPhNe is a company based in Singapore (Singapore) founded in 2011 by Subhasis Banerji and John Heng. SynPhNe has raised $5 million across 1 funding round from investors including Event Horizon Technologies. SynPhNe offers products and services including Wearable Solution. SynPhNe operates in a competitive market with competitors including Press & Say, NeuroStyle and XCLR8 Technologies, among others.
- Headquarter Singapore, Singapore
- Founders Subhasis Banerji, John Heng
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Synphne Pte. Ltd.
-
Annual Revenue
$60.94 K (USD)35as on Dec 31, 2023
-
Net Profit
-$2.33 M (USD)-373as on Dec 31, 2023
-
EBITDA
-$2.33 M (USD)-375as on Dec 31, 2023
-
Total Equity Funding
$5 M (USD)
in 1 rounds
-
Latest Funding Round
$5 M (USD), Series A
Mar 11, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SynPhNe
SynPhNe offers a comprehensive portfolio of products and services, including Wearable Solution.
Wearable that supports people with disabilities in daily and therapeutic activities.
Funding Insights of SynPhNe
SynPhNe has successfully raised a total of $5M through 1 strategic funding round. The most recent funding activity was a Series A round of $5 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SynPhNe
SynPhNe has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Event Horizon Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for SynPhNe
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SynPhNe
Investment portfolio details for SynPhNe
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SynPhNe
Detailed financials for SynPhNe
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synphne Comparisons
Peer comparison for SynPhNe
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SynPhNe
SynPhNe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Press & Say, NeuroStyle and XCLR8 Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of rehabilitation process for visually impaired
|
|
| Locked | Locked | Locked |
Manufactures neurological diagnostic equipment and rehabilitation systems for healthcare clients.
|
|
| Locked | Locked | Locked |
Offers wearable sensor technology for remote rehabilitation solutions.
|
Detailed competitors of SynPhNe
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synphne
Complete news archive for SynPhNe
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SynPhNe
SynPhNe was founded in 2011 and raised its 1st funding round 13 years after it was founded.
SynPhNe is headquartered in Singapore, Singapore.
SynPhNe is a funded company, having raised a total of $5M across 1 funding round to date.
Annual revenue of SynPhNe is $60.94K as on Dec 31, 2023.
SynPhNe was established in 2011 in Singapore as a provider of wearable devices focused on neurorehabilitation. Operations center on developing and deploying technology for monitoring patients during rehabilitation processes. The company serves the healthcare sector, particularly in neurology, with devices that track physiological data. Leadership includes Subhasis Banerji as founder and managing director, alongside co-founder John Heng. Activities are based in Singapore, supporting regional medical applications.
SynPhNe's top competitors include Press & Say, NeuroStyle and XCLR8 Technologies.
SynPhNe offers Wearable Solution.
SynPhNe has 1 investor. Key investors include Event Horizon Technologies.